1. Daunorubicin associated to lipid core nanoparticles reduces atherosclerotic lesions, inflammation and cardiotoxicity in atherosclerosis rabbit model. (25th November 2020) Authors: Albuquerque, C.I; Tavares, E.R; Guido, M.C; Lopes, N.M; Baroni, R.V; Jensen, L; Silva, B.M.O; Kalil-Filho, R; Tavoni, T.M; Maranhao, R.C Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome. (25th November 2020) Authors: Guido, M.C; Lopes, N.M; Albuquerque, C.I; Tavares, E.R; Jensen, L; Pereira, L.V; Kalil-Filho, R; Laurindo, F.R.M; Maranhao, R.C Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment with methotrexate carried in lipid core nanoparticles prevents the development of diastolic dysfunction in septic rats. (25th November 2020) Authors: Lopes, N.M; Guido, M.C; Albuquerque, C.I; Jensen, L; Miura, V.M; Marinho, L.M; Maranhao, R.C Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗